![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, October 29, 2007 11:12:46 AM
UnDiet® and Good Nights Sleep® commercials are also being readied for October-November. Lastly is the scheduling of FabuLust® female stimulant. “Our plate is full and we are expecting to generate significant revenue from these activities as the company moves into full swing for the coming retail season,” said Kravitz.
CEO Paul Kravitz, reports the re-opening of the United Kingdom market with its SnorAway® brand snore relief formula. “At one time our Snorenz® brand did over $1 million in sales and was very well received in the UK, unfortunately our distributor at that time re-engineered the formula and took the product for its own. We were totally unprotected,” said Kravitz. “Now we have another opportunity and we expect to rapidly grow the business.” The company has also received another 5,000-unit order from its Australian distributor.
Fabulust™, female stimulant, the company’s newest product, will be marketed in print advertisements in national magazines during the late fall and winter of 2007. Fabulust™ will also be featured on its own internet site as well as on www.medgen.com, the company site.
Along with FABULUST®, the company is now finishing two new commercials for its Painenz® and Snorenz® products. These commercials will air in late October and run through 2008.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM